NasdaqGS:TXGLife Sciences
Is 10x Genomics (TXG) Using PharosAI’s NHS Partnership To Quietly Recast Its Spatial Biology Moat?
In early February 2026, PharosAI announced it will use 10x Genomics’ Xenium spatial platform to convert thousands of archived NHS cancer samples into high-resolution, multimodal datasets for AI-driven research, backed by PS18.9 million in UK government funding plus additional charity and industry support.
This collaboration links 10x Genomics’ spatial biology technology with a major UK cancer initiative that plans to democratize AI-ready datasets for global researchers, clinicians and...